ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 175 filers reported holding ANTARES PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $592,000 | +15.2% | 144,400 | +0.3% | 0.00% | – |
| Q4 2021 | $514,000 | -52.1% | 143,900 | -51.2% | 0.00% | – |
| Q3 2021 | $1,073,000 | +71.1% | 294,879 | +104.9% | 0.00% | – |
| Q2 2021 | $627,000 | +15.3% | 143,900 | +8.8% | 0.00% | – |
| Q1 2021 | $544,000 | -9.3% | 132,300 | -12.0% | 0.00% | – |
| Q4 2020 | $600,000 | +56.7% | 150,400 | +6.0% | 0.00% | – |
| Q3 2020 | $383,000 | -8.4% | 141,900 | -6.6% | 0.00% | – |
| Q2 2020 | $418,000 | +15.8% | 151,900 | -0.7% | 0.00% | – |
| Q1 2020 | $361,000 | -49.8% | 153,000 | 0.0% | 0.00% | – |
| Q4 2019 | $719,000 | +40.4% | 153,000 | 0.0% | 0.00% | – |
| Q3 2019 | $512,000 | +1.8% | 153,000 | 0.0% | 0.00% | – |
| Q2 2019 | $503,000 | +17.2% | 153,000 | +8.1% | 0.00% | – |
| Q1 2019 | $429,000 | +15.6% | 141,600 | +3.9% | 0.00% | – |
| Q4 2018 | $371,000 | +12.8% | 136,300 | +39.1% | 0.00% | – |
| Q3 2018 | $329,000 | +49.5% | 98,000 | +14.9% | 0.00% | – |
| Q2 2018 | $220,000 | +60.6% | 85,300 | +36.9% | 0.00% | – |
| Q1 2018 | $137,000 | +38.4% | 62,300 | +25.6% | 0.00% | – |
| Q4 2017 | $99,000 | -17.5% | 49,600 | +34.4% | 0.00% | – |
| Q3 2017 | $120,000 | +0.8% | 36,900 | 0.0% | 0.00% | – |
| Q2 2017 | $119,000 | -27.0% | 36,900 | -80.2% | 0.00% | – |
| Q1 2016 | $163,000 | -31.5% | 186,800 | -5.1% | 0.00% | – |
| Q4 2015 | $238,000 | -29.0% | 196,800 | -0.3% | 0.00% | – |
| Q3 2015 | $335,000 | -18.3% | 197,300 | 0.0% | 0.00% | – |
| Q2 2015 | $410,000 | -23.4% | 197,300 | 0.0% | 0.00% | – |
| Q1 2015 | $535,000 | +5.5% | 197,300 | 0.0% | 0.00% | – |
| Q4 2014 | $507,000 | +33.4% | 197,300 | -5.1% | 0.00% | – |
| Q3 2014 | $380,000 | -35.6% | 207,900 | -6.0% | 0.00% | – |
| Q2 2014 | $590,000 | -23.9% | 221,100 | -0.1% | 0.00% | -100.0% |
| Q1 2014 | $775,000 | -25.8% | 221,389 | -5.1% | 0.00% | 0.0% |
| Q4 2013 | $1,045,000 | +4.1% | 233,223 | -5.7% | 0.00% | 0.0% |
| Q3 2013 | $1,004,000 | +3.8% | 247,223 | +6.3% | 0.00% | 0.0% |
| Q2 2013 | $967,000 | – | 232,498 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,180,000 | 4.34% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,535,727 | $11,056,000 | 3.87% |
| Sargent Investment Group, LLC | 3,596,250 | $15,680,000 | 3.72% |
| Rubric Capital Management LP | 9,500,000 | $41,420,000 | 2.61% |
| PERKINS CAPITAL MANAGEMENT INC | 541,783 | $2,362,000 | 1.34% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $8,284,000 | 1.14% |
| Venator Capital Management Ltd. | 709,700 | $3,094,000 | 1.05% |
| LEVEL FOUR FINANCIAL, LLC | 120,000 | $523,000 | 0.22% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $875,000 | 0.19% |
| Brown Advisory Securities, LLC | 275,000 | $1,199,000 | 0.19% |